The abrupt discontinuation of a clinical trial of a potential Down syndrome therapy shocked parents and researchers, who saw the promise of the drug. What happened?
Low levels of cellular copper appear to make fat cells fatter by altering how they process their main metabolic fuels, such as fat and sugar, study finds